Scandinavian ChemoTech AB (publ) announced that its tumour treatment product; IQwave, has been officially certified for use in Singapore. This certification represents an achievement in the Company's mission to provide innovative solutions for cancer treatment, further solidifying IQwave's commitment to improving patient outcomes. IQwave's advanced tumour treatment technology offers a non-invasive approach to targeting and treating tumours with exceptional precision, while minimizing the impact on surrounding healthy tissue.

The certification from regulatory authorities in Singapore underscores the safety, efficacy, and quality of IQwave's product, paving the way for its adoption in clinical settings across the country. When the Company decides to include Singapore in the market plan, the approval will become crucial, setting the stage for optimal conditions.